Erratum to: Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases
Cancer Cell International volume 10, Article number: 37 (2010)
After publication of this work , we noted that we inadvertently failed to properly acknowledge all of our funding agencies. The acknowledgements section has now been modified accordingly.
Ager E, Chong W, Wen SW, Christophi C: Targeting the antiogensin II type 2 receptor (AT2R) in colorectal liver metastases. Cancer Cell Int. 2010, 10: 19-10.1186/1475-2867-10-19.
This work was supported by Cancer Australia's Priority-driven Collaborative Cancer Research Scheme and is co-funded by Cancer Australia and Cure Cancer Australia Foundation. We would also like to thank the CanToo fund raisers. Dr Ager is supported by an NHMRC Post-doctoral Training Award. Ms Shu-wen Wen is supported by an Australian Rotary Health Research Fund PhD Scholarship. We would like to thank Professor Mauro Sandrin and his team from the xenotransplantation group at Austin Health (Australia), Dr Russell Hodgson and Claire Lin, for their help with CFSE and PI staining and analysis.
The online version of the original article can be found at 10.1186/1475-2867-10-19
About this article
Cite this article
Ager, E.I., Chong, W.W., Wen, Sw. et al. Erratum to: Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases. Cancer Cell Int 10, 37 (2010). https://doi.org/10.1186/1475-2867-10-37